Epidemiological data from hantavirus IgM-ELISA positive samples collected from symptomatic patients between 2003 and 2012 used in the clinical sensitivity/specificity panel.
Serological tests have been widely used for detecting human T-cell lymphotropic virus type 1/2 (HTLV-1/2) antibodies in the endemic areas, but their performance in low-risk populations is rarely repor